All canine diagnoses

Your dog was diagnosed with Insulinoma (Pancreatic Beta-Cell Tumour). Uncommon but clinically significant tumour. Presents with paraneoplastic hypoglycaemia (weakness, collapse, seizures). Most are malignant with metastatic potential to liver and regional lymph nodes. Compare 2 treatment options for dogs including Partial Pancreatectomy ± Metastasectomy, Medical Management (Diazoxide ± Prednisolone) — with survival times, costs, and what to expect during treatment.

🐕

Insulinoma (Pancreatic Beta-Cell Tumour)

Stage I (pancreas only) to Stage III (metastatic)

BreedsGerman ShepherdIrish SetterBoxerGolden RetrieverStandard PoodleFox TerrierFlat-Coated RetrieverLabrador Retriever
canine

Neuroendocrine

About This Cancer

Insulinoma is a tumour of the insulin-producing beta cells of the pancreas. Because the tumour cells retain the ability to secrete insulin — often in excess and without the normal regulatory controls — the hallmark of this cancer is dangerously low blood sugar (hypoglycaemia). Affected dogs may show weakness, disorientation, trembling, or even seizures, particularly after fasting or exercise. The symptoms can be intermittent, as insulin release from the tumour may fluctuate. Most insulinomas are malignant, though they tend to be slow-growing. Spread is most commonly to the liver and regional lymph nodes. Surgical removal of the tumour can provide significant benefit, and medical management with dietary changes and medications that counter insulin's effects can help maintain stable blood sugar levels. German Shepherds, Irish Setters, and Golden Retrievers are among the breeds at higher risk.

Modified clinical staging for canine insulinoma

Based on extent of disease at surgery

Stage ITumour confined to pancreas
Stage IITumour with regional lymph node metastasis
Stage IIIDistant metastasis present (liver, omentum)
Prognostic Factors(2)
Stage at surgeryHigher stage associated with shorter disease-free interval and survival(Polton et al., 2007)
Completeness of excisionComplete excision with immediate resolution of hypoglycaemia carries better prognosis(Cleland et al., 2020)
Minimum Workup(5 steps)
1Fasting blood glucose and paired insulin measurement (inappropriately high insulin with hypoglycaemia)
2Abdominal ultrasound (pancreatic mass, hepatic metastases)
3CT abdomen (staging, surgical planning)
4Thoracic radiographs
5Complete blood count and biochemistry panel

Median Survival Time Comparison

How long the average patient survives with each treatment

Bar opacity reflects evidence strength
Partial Pancreatectomy ± Metastasectomy
~18 mo (12–26)
Medical Management (Diazoxide ± Prednisolone)
~4 mo (2.5–6.5)
Reading this page: MST (Median Survival Time) is how long the average patient survives with a given treatment. ORR (Overall Response Rate) is the percentage of patients whose tumour shrank or disappeared. CR = Complete Response (tumour gone); PR = Partial Response (tumour shrank). Hover over any abbreviation for a quick explanation.
Strength of Evidence

Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.

StrongLarge published studies with strong agreement among veterinary oncologists.
ModerateWidely used in clinical practice, but supported by smaller or retrospective studies.
IndirectEvidence comes from a different tumour type or species and has been applied here.
LimitedVery little published data is available for this specific treatment.

Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.